Austin Aerts
Chief Financial Officer
Replay available
Sera Prognostics, Inc. (NASDAQ: SERA) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Head of Investor Relations
President and Chief Executive Officer
Analyst, Jefferies
Analyst, Craig-Hallum Capital Group
Analyst, TD Cowen
Analyst, William Blair
Good afternoon, ladies and gentlemen, and welcome to CERA Prognostics Second Quarter 2026 Financial Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star 0 for the operator. This call is being recorded on Wednesday, August 12, 2026. I would now like to turn the conference over to Jennifer Zibuda. Head of Investor Relations. Please go ahead. Thank you, Operator. Welcome to SARA Prognostics' second quarter 2026 earnings conference call. Earlier today, SARA reported financial results for the quarter ended June 30, 2026. Joining me on today's call are Zhenya Lindgardt, President and Chief Executive Officer, and Austin Aerts, Chief Financial Officer. Following our prepared remarks, we will open the call for questions. A copy of today's earnings release can be found in the Investors section of our website at SARA.com, and a replay of this webcast will also be available. Before we begin, please note that today's discussion will include projections or forward-looking statements around events and circumstances that have not yet occurred, including regarding our business, future financial results and performance, and market opportunities. These statements are based on our current expectations and are subject to risk factors and uncertainties that could cause actual results to differ materially and adversely from these expectations and forward-looking statements. Please refer to our filings with the Securities and Exchange Commission, including our most recent forms 10-K, 10-Q, and 8-K, for important information regarding these risk factors. With that, I will turn the call over to Zhenya. Thank you, Je...